Deltex Medical Group plc
DEMG.L · LSE
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | £3,223 | £2,406 | £8,446 | £6,990 |
| - Cash | £326 | £705 | £107 | £471 |
| + Debt | £1,983 | £1,921 | £2,348 | £2,233 |
| Enterprise Value | £4,880 | £3,622 | £10,687 | £8,752 |
| Revenue | £1,064 | £717 | £1,059 | £1,324 |
| % Growth | 48.4% | -32.3% | -20% | – |
| Gross Profit | £711 | £397 | £708 | £967 |
| % Margin | 66.8% | 55.4% | 66.9% | 73% |
| EBITDA | -£403 | -£655 | -£399 | -£345 |
| % Margin | -37.9% | -91.4% | -37.7% | -26.1% |
| Net Income | -£546 | -£745 | -£538 | -£483 |
| % Margin | -51.3% | -103.9% | -50.8% | -36.5% |
| EPS Diluted | -0 | -0 | -0.001 | -0.001 |
| % Growth | 25% | 50% | -14.3% | – |
| Operating Cash Flow | -£435 | -£890 | -£305 | £46 |
| Capital Expenditures | -£11 | -£3 | -£242 | -£394 |
| Free Cash Flow | -£446 | -£893 | -£547 | -£348 |